profit from every $100 of sales.
$0$100
Solventum
$90.08-0.39% today
+19.8% in 1 year
1-year low $62.491-year high $92.44
Trading close to its highest price of the past year.
The essentials
Four questions every investor asks, answered in one line each.
more sales each year, on average, 2022 to 2025.
0%20% a year
You pay $9.84 for every $1 of profit it makes in a year.
CheapExpensive
of earnings would pay off all its debt.
No debt5 years
Money in, money out
What Solventum sold, what it kept, and what it did with the cash.
Sales went from $8.13 billion in 2022 to $8.33 billion in 2025, with $1.56 billion of profit last year.
SalesProfit
Solventum vs. similar companies
Solventum grows in the middle of these 5 and is the cheapest for its profits.
| Company | Profit from $100 of sales | Sales growth a year | Price per $1 of profit |
|---|---|---|---|
| Solventum | 9.8× · Cheap | ||
 Tenet Healthcare | 16.4× · Fair price | ||
 Encompass Health | 24.7× · Fair price | ||
 Fresenius Medical Care AG & Co. KGaA | 10.8× · Cheap | ||
 DaVita | 15.1× · Fair price |
AI analysis
An AI analyst reads Solventum's last five years, its segments, earnings, insiders and peers, and writes the bull case, the bear case and what the price expects.
Run the AI analysisFull statementsIncome, balance sheet and cash flow, year by year
Income statement
| In millions of USD | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|
| 8,130 | 8,197 | 8,254 | 8,325 | |
| 4,695 | 4,693 | 4,593 | 4,451 | |
| 1,693 | 1,636 | 1,036 | 632 | |
| 2,270 | 2,228 | 1,527 | 2,549 | |
| 1,343 | 1,346 | 479 | 1,556 | |
| 7.78 | 7.79 | 2.76 | 8.88 | |
| 57.7% | 57.3% | 55.6% | 53.5% | |
| 20.8% | 20.0% | 12.6% | 7.6% | |
| 16.5% | 16.4% | 5.8% | 18.7% |
Balance sheet
| In millions of USD | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|
| Total assets | 13,594 | 13,943 | 14,457 | 14,294 |
| Cash | 61 | 194 | 762 | 878 |
| Total debt | – | 8,303 | 8,010 | 5,035 |
| Total liabilities | 1,852 | 2,277 | 11,498 | 9,244 |
| 11,742 | 11,666 | 2,959 | 5,050 | |
| 173 | 173 | 174 | 175 | |
| 11.4% | 6.6% | 7.0% | 16.1% | |
| 11.4% | 11.5% | 16.2% | 30.8% |
Cash flow
| In millions of USD | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|
| 1,679 | 1,915 | 1,185 | 369 | |
| 251 | 290 | 380 | 379 | |
| 1,428 | 1,625 | 805 | -10 | |
| Dividends paid | – | – | – | – |
| – | – | – | – | |
| 37 | 39 | 112 | 161 |
Valuation
- 9.8×
- –
- 2.18
- 2.6×
- 1.8×
- –
- 7.6×
- -0.1%
- 10.2%
- 0.0%
Profitability
- 53.5%
- 7.6%
- 18.7%
- 33.4%
- 15.9%
- 10.0%
- 30.7%
- 10.2%
- 19.6%
- 8.9%
Growth
- +0.8%
- +4.5%
- −101.2%
- –
- +0.2%
Financial health
- 1.6×
- 1.02
- 36.0%
- 6.9×
- 1.07
- 0.75
- 0.59
How it ranks in Healthcare
Each dot is where the company stands among every company over $300M in the sector. Further right is better.
Top 14%of 945
Bottom 46%of 870
Top 9%of 559
Bottom 17%of 867
Bottom 41%of 986
Recent earnings
Our results feed has not updated since May 21, 2026. Results reported after that are not in this table yet.
| Date | EPS | Expected | Surprise |
|---|---|---|---|
| May 5, 2026 | 1.48 | 1.35 | +9.6% |
| Feb 26, 2026 | 1.57 | 1.50 | +4.7% |
| Nov 6, 2025 | 1.50 | 1.43 | +4.9% |
| Aug 7, 2025 | 1.69 | 1.45 | +16.6% |
| May 8, 2025 | 1.34 | 1.21 | +10.7% |
| Feb 27, 2025 | 1.41 | 1.31 | +7.6% |
| Nov 7, 2024 | 1.64 | 1.39 | +18.0% |
| Aug 8, 2024 | 1.56 | 1.51 | +3.3% |
News
No recent news on file.
Insider trades
Our insider feed has not updated since May 26, 2026. Trades filed after that are not listed yet.
No insider trades on file.
The seven classic investing rulebooks
1/7Passes 1 of 7. Each bar is how well the company fits that investor's published rules, from 0 to 100; 60 or more counts as a pass.
Warren Buffett
40No pass
Benjamin Graham
60Pass
Philip Fisher
49No pass
Peter Lynch
32No pass
Joel Greenblatt
56No pass
Charlie Munger
42No pass
Terry Smith
29No pass
Questions about Solventum
Is Solventum a good stock to buy?
A solid business, and the price looks low. 1 of the 7 famous investors' published rulebooks we apply pass it. Whether it suits you depends on your goals and the price you pay; invest-like never tells anyone to buy or sell. The AI analysis lays out the case for and against. Read the Solventum AI analysis
What does Solventum do?
Solventum Corporation, a healthcare company, engages in the developing, manufacturing, and commercializing a portfolio of solutions to address critical customer and patient needs. It is in Medical - Care Facilities, based in Eagan, MN, United States, with 20,584 employees.
Does Solventum pay a dividend?
No. Solventum does not pay a dividend at the moment.
Is Solventum stock halal?
Questionable. Solventum sits in a grey zone: its debt is 33% of its market value, between 30% and 33%. How we check
How has Solventum stock done over the past year?
Up 19.8% over the past twelve months, to $90.08. It traded between $62.49 and $92.44 and is 2.6% below its high.
Who are Solventum's competitors?
The largest listed companies in the same industry are Tenet Healthcare, Encompass Health, Fresenius Medical Care AG & Co. KGaA and DaVita. The peers table on this page compares their profit, growth and price with Solventum's.
Prices: daily closes to Nov 10, 2026. Fundamentals: company reports via invest-like data.